Literature DB >> 11361469

CD4 and CD8 lymphocytes in diagnosis and disease progression of pediatric HIV infection.

M C Aldhous1, G M Raab, J Y Mok, K V Doherty, A G Bird, K S Froebel.   

Abstract

Vertical infection with human immunodeficiency virus-1 (HIV-1) causes profound changes in the proportions of subpopulations of lymphocytes in the peripheral circulation. In this study the percentages in whole blood of CD4 and CD8 cells, and of immunologically important subpopulations, were measured in 19 HIV-infected children over periods of up to 4 years and compared to our recently published ranges for normal children of various ages. The rate of CD4 decline and of CD8 increase differed between clinically fast and slow progressors. On CD8 cells, cytotoxic, memory (CD11abright and CD45R0), and activation (HLA-DR) markers were raised soon after birth to levels outside the normal range, and compared favorably with HIV culture as a method for early diagnosis of HIV infection. Mean levels of naive (CD45RA) and memory (CD45R0, CD29) markers on CD4 cells became significantly altered after 48 months of age, suggesting that these are markers of more advanced disease. Despite different ages of enrollment into the study, in the cohort as a whole, the levels of the lymphocyte subpopulations studied changed consistently. Thus, their measurement could be useful both in the diagnosis and prognosis of HIV infection in individual children. This is the first report showing that lymphocyte subpopulation analysis can play a major role in the diagnosis of pediatric HIV infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 11361469

Source DB:  PubMed          Journal:  Pediatr AIDS HIV Infect        ISSN: 1045-5418


  4 in total

1.  Left ventricular structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group.

Authors:  S E Lipshultz; K A Easley; E J Orav; S Kaplan; T J Starc; J T Bricker; W W Lai; D S Moodie; K McIntosh; M D Schluchter; S D Colan
Journal:  Circulation       Date:  1998-04-07       Impact factor: 29.690

2.  Timing of lymphocyte activation in neonates infected with human immunodeficiency virus.

Authors:  K Gallagher; M Gorre; N Harawa; M Dillon; D Wafer; E R Stiehm; Y Bryson; D Song; R Dickover; S Plaeger
Journal:  Clin Diagn Lab Immunol       Date:  1997-11

3.  Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection.

Authors:  John S Lambert; Jack Moye; Susan F Plaeger; E Richard Stiehm; James Bethel; Lynne M Mofenson; Bonnie Mathieson; Jonathan Kagan; Howard Rosenblatt; Helene Paxton; Hildie Suter; Alan Landay
Journal:  Clin Diagn Lab Immunol       Date:  2005-05

4.  Routine inpatient provider-initiated HIV testing in Malawi, compared with client-initiated community-based testing, identifies younger children at higher risk of early mortality.

Authors:  Geoffrey A Preidis; Eric D McCollum; William Kamiyango; Alejandro Garbino; Mina C Hosseinipour; Peter N Kazembe; Gordon E Schutze; Mark W Kline
Journal:  J Acquir Immune Defic Syndr       Date:  2013-05-01       Impact factor: 3.731

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.